SEC Form 4 research
| Issuer | Nurix Therapeutics, Inc. |
|---|---|
| Tickers | NRIX |
| Reporting owners | 39 |
| Officers and directors | 6 |
| Last public filing | 2026-10-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-15 | 2026-10-15 | Hansen Gwenn | S | 1,452 | $25 | Not reported |
| 2026-10-14 | 2026-10-14 | GREGORY JULIA P | S | 22,583 | $23.4 | Not reported |
| 2026-10-02 | 2026-10-02 | Ring Christine | S | 5,786 | $23.19 | Not reported |
| 2026-09-02 | 2026-09-02 | Ring Christine | S | 400 | $26.64 | Not reported |
| 2026-09-02 | 2026-09-02 | Ring Christine | S | 5,387 | $25.69 | Not reported |
| 2026-09-01 | 2026-09-01 | Hansen Gwenn | S | 1,452 | $25.47 | Not reported |
| 2026-08-05 | 2026-08-05 | Hansen Gwenn | S | 4,356 | $25 | Not reported |
| 2026-08-05 | 2026-08-04 | Hansen Gwenn | S | 2,611 | $24.64 | Not reported |
| 2026-08-05 | 2026-08-04 | Hansen Gwenn | S | 1,500 | $23.87 | Not reported |
| 2026-08-04 | 2026-08-04 | van Houte Hans | S | 2,967 | $24.65 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.